← SynDRA
AMG-337
SynDRA canonical compound SYN0038548 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MET |
|---|
| Mechanism of action | MET inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MET INHIBITOR
- Hepatocyte growth factor receptor inhibitor
Cross-references
Synonyms
- AMG 337
- AMG337
- RefChem:111925
- C-MET INHIBITOR AMG 337
- AMG 337 [WHO-DD]
- MFCD29472283
- UNII-08WG8S0L8D
- AMG 337; Compound M;
- GTPL8913
- orb1304422
- SCHEMBL4304600
- SCHEMBL29582914
- C23H22FN7O3
- GLXC-90522
- YWB69931
- BDBM50157612
- NSC789223
- NSC800996
- s8167
- AKOS030526285
- CCG-269379
- CS-5281
- EBC-219059
- NSC-789223
- NSC-800996
- compound 24 [PMID: 19819693]
- NCGC00483923-01
- NCGC00483923-04
- AC-33036
- AS-75219
- DA-50393
- HY-18696
- T3209
- A488240
- BRD-K27061362-001-01-6
- 6-[(1~{R})-1-[8-fluoranyl-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-1,6-naphthyridin-5-one
- orb1739162
- AMG-337 monohydrate
Look up AMG-337 in the interactive SynDRA portal →